Form 4: Fulgent Genetics CEO's Stock Withholding

Sentiment:

Insider Transaction Report


Fulgent Genetics CEO Ming Hsieh reported a disposition of shares to cover tax obligations from vested restricted stock units.

Delay expectedThe reported transaction date (August 1, 2025) and the signature date (August 5, 2025) are in the future, which is highly unusual for a Form 4 filing that typically reports past changes in beneficial ownership. This suggests a potential error in dating or a pre-filing for a future event, which is not standard for Form 4.

Summary

  • Ming Hsieh, the Chief Executive Officer, Director, and 10% owner of Fulgent Genetics, Inc. (FLGT), reported a change in his beneficial ownership of common stock.
  • 1,339 shares of Common Stock were disposed of at a price of $18.53 per share.
  • This disposition was due to shares being withheld to satisfy tax withholding obligations that arose upon the vesting of restricted stock units (RSUs) granted to Mr. Hsieh on August 1, 2022.
  • Following this transaction, Mr. Hsieh directly owns 809,340 shares.
  • Indirectly, Mr. Hsieh beneficially owns 7,895,115 shares through the Dynasty Trust, 220,816 shares through The Ming Hsieh Trust, and 2,000 shares through Uniform Transfer to Minor Accounts, totaling 8,117,931 indirect shares.

Sentiment

Score: 5

Explanation: The filing reports a routine transaction (shares withheld for tax upon RSU vesting) which is neither inherently positive nor negative for the company's operations or outlook, but rather a standard compensation-related event for an executive.

Positives

  • The vesting of restricted stock units (RSUs) indicates the achievement of performance or time-based criteria, which is a positive event for the executive.

Negatives

  • A reduction of 1,339 shares from direct beneficial ownership due to tax withholding.

Future Outlook

NA

Industry Context

This filing is a routine insider transaction report and does not provide information related to broader industry trends or competitive landscape.

Related Party Transactions

  • Indirect beneficial ownership through the Dynasty Trust, where Mr. Hsieh is the grantor and serves on the investment committee.
  • Indirect beneficial ownership through The Ming Hsieh Trust, where Mr. Hsieh is the trustee and possesses sole voting and dispositive power.
  • Indirect beneficial ownership through Uniform Transfers to Minor Act accounts, where Mr. Hsieh acts as custodian and possesses sole voting and dispositive power.

Stakeholder Impact

  • Shareholders: The disposition of shares for tax withholding is a minor, routine event with negligible direct impact on the overall share structure or value.
  • Employees: No direct impact on the broader employee base.

Key Dates

DateDescription
08/01/2022Date restricted stock units were originally granted to the reporting person.
08/03/2022Date the original Form 4 was filed with the U.S. Securities and Exchange Commission regarding the RSU grant.
08/01/2025Reported transaction date for the disposition of shares due to RSU vesting and tax withholding.
08/05/2025Signature date of the reporting person's attorney-in-fact.

Recommendation

hold

This Form 4 reports a routine disposition of shares by the CEO to cover tax obligations arising from the vesting of restricted stock units. Such transactions are common and do not typically indicate a change in the company's fundamental performance or outlook, thus not warranting a change in investment recommendation based solely on this filing.

Keywords

Fulgent Genetics, FLGT, Ming Hsieh, SEC Form 4, insider transaction, stock ownership, restricted stock units, RSU vesting, tax withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.